Krka dd Novo mesto
Krka dd Novo mesto is a Slovenian international pharmaceutical company manufacturing generic prescription pharmaceuticals and over-the-counter products. The company researches, produces, and markets generic cardiovascular drugs, central nervous system therapies, gastrointestinal medicines, oncology products, and animal health remedies. Main revenue drivers consist of global commercial sales of generic prescription drugs, OTC healthcare products, and veterinary pharmaceuticals. Krka serves prescription pharmacies, hospital networks, healthcare institutions, and patients across Central, Eastern, and Western Europe, and Asia. The company holds a market-leading position as a premier generic pharmaceutical manufacturer in Central and Eastern Europe. Headquartered in Novo Mesto, Slovenia, Krka dd Novo mesto is listed on the Ljubljana Stock Exchange and Warsaw Stock Exchange.
3 of the funds FundTelligence covers report a position in Krka dd Novo mesto.
- Sector
- Health Care
- Country
- Slovenia
- Funds holding it
- 3
Funds holding Krka dd Novo mesto
- Schroder ISF Frontier Markets Equity — Schroders · 3.47 % (full portfolio disclosed, June 2026)
- Schroder ISF Emerging Europe — Schroders · 0.91 % (full portfolio disclosed, June 2026)
- Swedbank Robur Emerging Europe — Swedbank · 0.56 % (full portfolio disclosed, October 2026)